Literature DB >> 24745327

Prostaglandin E2: the villain in the host response to influenza virus.

Florian Full1, Michaela U Gack2.   

Abstract

Prostaglandins are lipid mediators that are involved in a plethora of biological processes. In this issue of Immunity, Coulombe et al. (2014) report that prostaglandin E2 suppresses innate and adaptive immune responses to influenza virus.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24745327     DOI： 10.1016/j.immuni.2014.03.008

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  6 in total

Review 1.  Prostaglandin E2 as a Regulator of Immunity to Pathogens.

Authors:  Giovanny J Martínez-Colón; Bethany B Moore
Journal:  Pharmacol Ther       Date:  2017-12-22       Impact factor: 12.310

Review 2.  Decrypting the cellular and molecular intricacies associated with COVID-19-induced chronic pain.

Authors:  Mousmi Rani; Ankit Uniyal; Vinod Tiwari
Journal:  Metab Brain Dis       Date:  2022-07-18       Impact factor: 3.655

3.  Inhibition of viral and bacterial trigger-stimulated prostaglandin E2 by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell line.

Authors:  Rob Lambkin-Williams; Alex Mann; Adrian Shephard
Journal:  SAGE Open Med       Date:  2020-09-24

4.  Early steroid pulse therapy among children with influenza virus-associated encephalopathy.

Authors:  Takeshi Hatachi; Nobuaki Michihata; Muneyuki Takeuchi; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  J Intensive Care       Date:  2020-08-12

Review 5.  The Role of Lipid Metabolism in Influenza A Virus Infection.

Authors:  Yong Zhou; Juan Pu; Yuping Wu
Journal:  Pathogens       Date:  2021-03-05

6.  Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.

Authors:  Melanie Ricke-Hoch; Elisabeth Stelling; Lisa Lasswitz; Antonia P Gunesch; Martina Kasten; Francisco J Zapatero-Belinchón; Graham Brogden; Gisa Gerold; Thomas Pietschmann; Virginie Montiel; Jean-Luc Balligand; Federica Facciotti; Emilio Hirsch; Thomas Gausepohl; Husni Elbahesh; Guus F Rimmelzwaan; Anne Höfer; Mark P Kühnel; Danny Jonigk; Julian Eigendorf; Uwe Tegtbur; Lena Mink; Michaela Scherr; Thomas Illig; Axel Schambach; Tobias J Pfeffer; Andres Hilfiker; Axel Haverich; Denise Hilfiker-Kleiner
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.